Abstract
Patient administration errors in the use of beclomethasone dipropionate aerosol are frequent. Asthmatics once labeled “treatment failures” on this aerosol may only need adequate consultation to achieve therapeutic results. Pharmacists should monitor for patient noncompliance and provide instruction and follow-up on the use of beclomethasone dipropionate aerosol.
Common administration errors associated with this drug are described, along with information patients should receive to obtain optimal benefits.
Get full access to this article
View all access options for this article.
